Chapter 34. New Drugs for the Management of Hepatitis C

  1. Howard Thomas BSc PhD FRCP FRCpath FMedSci Professor1,
  2. Stanley Lemon Professor2 and
  3. Arie Zuckerman MD, DSc, FRCP, FRCPath, FMedSci, Dip. Bact Professor3
  1. John G McHutchison,
  2. Jennifer M King and
  3. Amany Zekry

Published Online: 26 OCT 2007

DOI: 10.1002/9780470987131.ch34

Viral Hepatitis, Third Edition

Viral Hepatitis, Third Edition

How to Cite

McHutchison, J. G., King, J. M. and Zekry, A. (2005) New Drugs for the Management of Hepatitis C, in Viral Hepatitis, Third Edition (eds H. Thomas, S. Lemon and A. Zuckerman), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987131.ch34

Editor Information

  1. 1

    Dean (Clinical) Faculty of Medicine, Imperial College, Department of Medicine, Queen Elizabeth Queen Mother Wing, St Mary's Hospital Medical School, London UK

  2. 2

    Dean of Medicine, Department of Microbiology & Immunology & Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA

  3. 3

    The Royal Free Hospital of Medicine, Rowland Hill Street, London, UK

Publication History

  1. Published Online: 26 OCT 2007
  2. Published Print: 12 JUL 2005

ISBN Information

Print ISBN: 9781405130059

Online ISBN: 9780470987131



  • managmement of hepatitis C;
  • hepatitis C virus (HCV) infection;
  • HCV life-cycle;
  • RNA replication;
  • antisense oligonucleotides


This chapter contains sections titled:

  • Introduction

  • The HCV life-cycle and potential inhibitors

  • Host immune responses and immune therapies

  • Progression of liver disease

  • Conclusion